BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18193342)

  • 21. Impaired NFAT regulation and its role in a severe combined immunodeficiency.
    Feske S; Draeger R; Peter HH; Rao A
    Immunobiology; 2000 Aug; 202(2):134-50. PubMed ID: 10993288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Maillard MH; Cotta-de-Almeida V; Takeshima F; Nguyen DD; Michetti P; Nagler C; Bhan AK; Snapper SB
    J Exp Med; 2007 Feb; 204(2):381-91. PubMed ID: 17296786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency--lessons learned from monogenic disorders in mice and men.
    Westerberg LS; Klein C; Snapper SB
    Curr Opin Immunol; 2008 Dec; 20(6):646-54. PubMed ID: 18955138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimated disease incidence of RAG1/2 mutations: A case report and querying the Exome Aggregation Consortium.
    Kumánovics A; Lee YN; Close DW; Coonrod EM; Ujhazi B; Chen K; MacArthur DG; Krivan G; Notarangelo LD; Walter JE
    J Allergy Clin Immunol; 2017 Feb; 139(2):690-692.e3. PubMed ID: 27609655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic disorders with immune dysregulation.
    Gambineri E; Torgerson TR
    Cell Mol Life Sci; 2012 Jan; 69(1):49-58. PubMed ID: 21984607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction and maintenance of self tolerance: the role of CD4+CD25+ regulatory T cells.
    Bala KK; Moudgil KD
    Arch Immunol Ther Exp (Warsz); 2006; 54(5):307-21. PubMed ID: 17031470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune tolerance: are regulatory T cell subsets needed to explain suppression of autoimmunity?
    Tian L; Humblet-Baron S; Liston A
    Bioessays; 2012 Jul; 34(7):569-75. PubMed ID: 22419393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The viral enterprises in autoimmunity: conversion of target cells into de novo APCs is the presage to autoimmunity.
    Temajo NO; Howard N
    Autoimmun Rev; 2012 Jul; 11(9):653-8. PubMed ID: 22122867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How defects in central tolerance impinge on a deficiency in regulatory T cells.
    Chen Z; Benoist C; Mathis D
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14735-40. PubMed ID: 16203996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engraftment of human lymphocytes and thyroid tissue into scid and rag2-deficient mice: absent progression of lymphocytic infiltration.
    Martin A; Valentine M; Unger P; Yeung SW; Shultz LD; Davies TF
    J Clin Endocrinol Metab; 1994 Sep; 79(3):716-23. PubMed ID: 8077352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune regulator and self-tolerance - molecular and clinical aspects.
    Abramson J; Husebye ES
    Immunol Rev; 2016 May; 271(1):127-40. PubMed ID: 27088911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency (CID).
    Schuetz C; Niehues T; Friedrich W; Schwarz K
    Autoimmun Rev; 2010 May; 9(7):477-82. PubMed ID: 20146941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory T cells in primary immunodeficiency diseases.
    Torgerson TR; Ochs HD
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):515-21. PubMed ID: 17989528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From murine to human nude/SCID: the thymus, T-cell development and the missing link.
    Romano R; Palamaro L; Fusco A; Iannace L; Maio S; Vigliano I; Giardino G; Pignata C
    Clin Dev Immunol; 2012; 2012():467101. PubMed ID: 22474479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal autoimmunity results from the conditional deletion of Snai2 and Snai3.
    Pioli PD; Chen X; Weis JJ; Weis JH
    Cell Immunol; 2015 May; 295(1):1-18. PubMed ID: 25732600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omenn's syndrome occurring in patients without mutations in recombination activating genes.
    Gennery AR; Hodges E; Williams AP; Harris S; Villa A; Angus B; Cant AJ; Smith JL
    Clin Immunol; 2005 Sep; 116(3):246-56. PubMed ID: 15964782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility to lymphoid neoplasia in immunodeficient strains of nonobese diabetic mice.
    Chiu PP; Ivakine E; Mortin-Toth S; Danska JS
    Cancer Res; 2002 Oct; 62(20):5828-34. PubMed ID: 12384545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three faces of recombination activating gene 1 (RAG1) mutations.
    Patiroglu T; Akar HH; Van Der Burg M
    Acta Microbiol Immunol Hung; 2015 Dec; 62(4):393-401. PubMed ID: 26689875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmunity. Insights provided by the SCID mouse model.
    Jorgensen C; Bologna C; Sany J
    Rev Rhum Engl Ed; 1995; 62(7-8):519-24. PubMed ID: 8574616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.